Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-22-043144
Filing Date
2022-08-01
Accepted
2022-08-01 06:10:22
Documents
2
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea163625-13gintra_enveric.htm SC 13G 92360
2 JOINT FILING AGREEMENT ea163625ex99-1_enveric.htm EX-99.1 3988
  Complete submission text file 0001213900-22-043144.txt   98063
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Subject) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-53543 | Film No.: 221122672
SIC: 2834 Pharmaceutical Preparations

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

EIN.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G